SCHEMBL7722280

SCHEMBL7722280

CC(C)(C)OC(=O)N1C[C@H](NC(=O)[C@H](O)CCc2ccccc2)C[C@H]1C(=O)Nc1cnc2ccccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.43
HDAC4 P56524 2/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC8 Q9BY41 4/20 0.41
HDAC3 O15379 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
TRPV1 Q8NER1 8/20 0.39
EPHX2 P34913 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7726142 0.95 HDAC4 (0.42) SCN9AHDAC4HDAC1HDAC8HDAC3
SCHEMBL7729578 0.95 HDAC4 (0.42) SCN9AHDAC4HDAC1HDAC8HDAC3
SCHEMBL7729111 0.92 HDAC4 (0.39) SCN9AHDAC4HDAC1HDAC8HDAC3
SCHEMBL7729494 0.91 SCN9A (0.40) SCN9AHDAC4HDAC1HDAC8HDAC3
SCHEMBL7721989 0.90 SCN9A (0.37) SCN9AHDAC4HDAC1HDAC8HDAC3
SCHEMBL7729729 0.90 SCN9A (0.39) SCN9AHDAC4HDAC1HDAC8HDAC3
SCHEMBL7726553 0.90 PARP1 (0.38) SCN9AHDAC4HDAC1HDAC8HDAC3
SCHEMBL7731670 0.89 SCN9A (0.36) SCN9AHDAC4HDAC1HDAC8HDAC3
SCHEMBL7722336 0.89 SCN9A (0.36) SCN9AHDAC4HDAC1HDAC8HDAC3
SCHEMBL7728128 0.89 SCN9A (0.35) SCN9AHDAC4HDAC1HDAC8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed